يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"MADROSZYK A"', وقت الاستعلام: 0.77s تنقيح النتائج
  1. 1
    مؤتمر
    LBA41 Nivolumab (nivo) ± ipilimumab (ipi) in pre-treated patients with advanced, refractory pulmonary or gastroenteropancreatic poorly differentiated neuroendocrine tumors (NECs) (GCO-001 NIPINEC)

    المؤلفون: Girard, N., Mazieres, J., Otto, J., Lena, H., Lepage, C., Egenod, T., Smith, D., Madelaine, J., Gérinière, L., El Hajbi, F., Ferru, A., Clément-Duchêne, C., Madroszyk, A., Desrame, J., Morin, F., Langlais, A., Michel, P., Louvet, C., Westeel, V., Walter, Thomas

    المساهمون: Hospices Civils de Lyon (HCL), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard Lyon -Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon, Hôpital Edouard Herriot CHU - HCL

    المصدر: Annals of Oncology ; Abstract Book of the ESMO Congress 2021, 16 – 21 September ; https://hal.science/hal-04492251Test ; Abstract Book of the ESMO Congress 2021, 16 – 21 September, Sep 2021, Paris, France. pp.S1318, ⟨10.1016/j.annonc.2021.08.2119⟩

    مصطلحات موضوعية: [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology

    جغرافية الموضوع: Paris, France

    العلاقة: hal-04492251; https://hal.science/hal-04492251Test

    الإتاحة: https://doi.org/10.1016/j.annonc.2021.08.2119Test
    https://hal.science/hal-04492251Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    مؤتمر
    LBA41 Nivolumab (nivo) ± ipilimumab (ipi) in pre-treated patients with advanced, refractory pulmonary or gastroenteropancreatic poorly differentiated neuroendocrine tumors (NECs) (GCO-001 NIPINEC)

    المؤلفون: Girard, N., Mazieres, J., Otto, J., Lena, H., Lepage, C., Egenod, T., Smith, D., Madelaine, J., Gérinière, L., El Hajbi, F., Ferru, A., Clément-Duchêne, C., Madroszyk, A., Desrame, J., Morin, F., Langlais, A., Michel, P., Louvet, C., Westeel, V., Walter, Thomas

    المساهمون: Hospices Civils de Lyon (HCL), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard Lyon -Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon, Hôpital Edouard Herriot CHU - HCL

    المصدر: Annals of Oncology ; Abstract Book of the ESMO Congress 2021, 16 – 21 September ; https://hal.science/hal-04492251Test ; Abstract Book of the ESMO Congress 2021, 16 – 21 September, Sep 2021, Paris, France. pp.S1318, ⟨10.1016/j.annonc.2021.08.2119⟩

    مصطلحات موضوعية: [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology

    جغرافية الموضوع: Paris, France

    العلاقة: hal-04492251; https://hal.science/hal-04492251Test

    الإتاحة: https://doi.org/10.1016/j.annonc.2021.08.2119Test
    https://hal.science/hal-04492251Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    مؤتمر
    LBA41 Nivolumab (nivo) ± ipilimumab (ipi) in pre-treated patients with advanced, refractory pulmonary or gastroenteropancreatic poorly differentiated neuroendocrine tumors (NECs) (GCO-001 NIPINEC)

    المؤلفون: Girard, N., Mazieres, J., Otto, J., Lena, H., Lepage, C., Egenod, T., Smith, D., Madelaine, J., Gérinière, L., El Hajbi, F., Ferru, A., Clément-Duchêne, C., Madroszyk, A., Desrame, J., Morin, F., Langlais, A., Michel, P., Louvet, C., Westeel, V., Walter, Thomas

    المساهمون: Hospices Civils de Lyon (HCL), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard Lyon -Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon, Hôpital Edouard Herriot CHU - HCL

    المصدر: Annals of Oncology ; Abstract Book of the ESMO Congress 2021, 16 – 21 September ; https://hal.science/hal-04492251Test ; Abstract Book of the ESMO Congress 2021, 16 – 21 September, Sep 2021, Paris, France. pp.S1318, ⟨10.1016/j.annonc.2021.08.2119⟩

    مصطلحات موضوعية: [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology

    جغرافية الموضوع: Paris, France

    العلاقة: hal-04492251; https://hal.science/hal-04492251Test

    الإتاحة: https://doi.org/10.1016/j.annonc.2021.08.2119Test
    https://hal.science/hal-04492251Test

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث